ALCOHOL - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for alcohol and what is the scope of freedom to operate?
Alcohol
is the generic ingredient in two branded drugs marketed by Bpi Labs and 3M, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are forty-one drug master file entries for alcohol. One supplier is listed for this compound.
Summary for ALCOHOL
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Drug Master File Entries: | 41 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 476 |
| Clinical Trials: | 1,969 |
| Drug Prices: | Drug price trends for ALCOHOL |
| What excipients (inactive ingredients) are in ALCOHOL? | ALCOHOL excipients list |
| DailyMed Link: | ALCOHOL at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ALCOHOL
Generic Entry Date for ALCOHOL*:
Constraining patent/regulatory exclusivity:
INDICATED TO INDUCE CONTROLLED CARDIAC SEPTAL INFRACTION TO IMPROVE EXERCISE CAPACITY IN ADULTS WITH SYMPTOMATIC HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY WHO ARE NOT CANDIDATES FOR SURGICAL MYECTOMY Dosage:
SOLUTION;INTRA-ARTERIAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for ALCOHOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Biozeus Biopharmaceutical S.A. | Phase 2 |
| Jessica Weafer | Early Phase 1 |
| Shupei Li | N/A |
US Patents and Regulatory Information for ALCOHOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bpi Labs | ABLYSINOL | alcohol | SOLUTION;INTRA-ARTERIAL | 207987-002 | Jun 21, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| 3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bpi Labs | ABLYSINOL | alcohol | SOLUTION;INTRA-ARTERIAL | 207987-001 | Jun 21, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
